TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
Loading market information…
OTC · SYDRF · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Delota Corp. operates as a Canadian retail company, primarily focusing on the sale of diverse cannabis products. Their product range also encompasses various vaping and nicotine-related items, herbal vaporizers, and other smoking cessation solutions, along with their complementary accessories. The firm manages a network of 26 brick-and-mortar retail establishments complemented by an online e-commerce platform. These operations are conducted under its two prominent brands: 180 Smoke and Offside Cannabis. The company, which is headquartered in Concord, Canada, transitioned its name to Delota Corp. in November 2021, having previously been recognized as Spyder Cannabis Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.75+CA$0.19 (+0.67%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.3% below the high.
$0.44+$0.02 (+4.76%)
Bio Essence Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.89% below the high.
$0.01$0.00 (0.0%)
Polarean Imaging plc’s quoted price sits in the upper half of its reported 52-week range, 1.49% below the high.
$2.84$0.00 (0.0%)
Talis Biomedical Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
A$0.01A$0.00 (0.0%)
Acrux Limited’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.00$0.00 (0.0%)
AXIM Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.66% below the high.
$0.00+$0.00 (+50.0%)
LiveWire Ergogenics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.57% below the high.
$0.01$0.00 (0.0%)
Encision Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.4% below the high.
